Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer

British Journal of Cancer

Volumn 101, Issue 1, 2009, Pages 91-97

  Hlund, D ^a   Lundin, C ^a   Ardnor, B ^a   Man, M ^a   Naredi, P ^a   Sund, M ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Basement membrane; Biomarker; Circulation; Extracellular matrix; Pancreas; Surgery

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 4; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; MALE; PANCREAS CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA; WESTERN BLOTTING; ADENOCARCINOMA; ADULT; AGED; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; METHODOLOGY; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; STROMA CELL; TUMOR CELL LINE;

ADENOCARCINOMA; ADULT; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COLLAGEN TYPE IV; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 67649842536     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605107     Document Type: Article

References (34)

1. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R, Howell SB (1996) Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res 56: 3087 - 3090
2. Bouterfa H, Darlapp AR, Klein E, Pietsch T, Roosen K, Tonn JC (1999) Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions. J Neuro-Oncol 44: 23 - 33
3. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R (2000) Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 60: 2520-2526
4. Ding J, Kashtan CE, Fan WW, Kleppel MM, Sun MJ, Kalluri R, Neilson EG, Michael AF (1994) A monoclonal antibody marker for Alport syndrome identifies the Alport antigen as the alpha 5 chain of type IV collagen. Kidney Int 45: 1504-1506
5. Goldstein D, Carroll S, Apte M, Keogh G (2004) Modern management of pancreatic carcinoma. Int Med J 34: 475 - 481
6. Gower WJ (1994) HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line. In Vitro Cell Dev Biol 30A: 151-161
7. Grzesiak JJ, Bouvet M (2007) Determination of the ligand-binding specificities of the alpha2beta1 and alpha1beta1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer. Pancreas 34: 220-228
8. Grzesiak JJ, Ho JC, Moossa AR, Bouvet M (2007) The integrin-extracellular matrix axis in pancreatic cancer. Pancreas 35: 293 - 301
9. Hamano Y, Zeisberg M, Sugimoto H, Lively JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A, Kalluri R (2003) Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 3: 589-601
10. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport's syndrome, Goodpasture's syndrome, and type IV collagen. New Engl J Med 348: 2543-2556
11. Huveneers S, Truong H, Danen HJ (2007) Integrins: signaling, disease, and therapy. Int J Radiation Biol 83: 743-751
12. Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687
13. Johansson C, Butkowski R, Wieslander J (1991) Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res 25: 229-241
14. Kadono G, Ishihara T, Yamaguchi T, Kato K, Kondo F, Naito I, Sado Y, Saisho H (2004) Immunohistochemical localization of type IV collagen alpha chains in the basement membrane of the pancreatic duct in human normal pancreas and pancreatic diseases. Pancreas 29: 61 - 66
15. Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev 3: 422 - 433
16. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275: 1209-1215
17. Karagiannis ED, Popel AS (2007) Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties. Biochem Biophys Res Commun 354:434-439
18. Khoshnoodi J, Pedchenko V, Hudson BG (2008) Mammalian collagen IV. Microsc Res Tech 71: 357 - 370
19. Kimura W, Kuroda A, Makuuchi M (1998) Problems in the diagnosis and treatment of a so-called mucin-producing tumor of the pancreas. Pancreas 16: 363-369
20. Kimura W, Ma J, Takeshita A, Yamamoto T, Moriya T, Hirai I, Fuse A (2007) Analysis of c-kit protein expression in pancreatic neoplasms and its implication for prognosis. Hepato-Gastroenterol54: 2203 - 2208
21. Korenaga D, Orita H, Maekawa S, Itasaka H, Ikeda T, Sugimachi K (1998) Peritoneal collagen type IV concentration in adenocarcinoma of the gastrointestinal tract and its relationship to histological differentiation, metastasis, and survival. Surg Today 28: 780- 786
22. Lee CS, Montebello J, Georgiou T, Rode J (1994) Distribution of type IV collagen in pancreatic adenocarcinoma and chronic pancreatitis. Int J Exp Pathol 75: 79- 83
23. Linder S, Castanos-Velez E, von Rosen A, Biberfeld P (2001) Immuno- histochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepato-Gastroenterol 48: 1321 - 1327
24. Lohr M, Trautmann B, Gottler M, Peters S, Zauner I, Maillet B, Kloppel G (1994) Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer 69: 144- 151
25. Murphy NC, Scarlett CJ, Kench JG, Sum EY, Segara D, Colvin EK, Susanto J, Cosman PH, Lee CS, Musgrove EA, Sutherland RL, Lindeman GJ, Henshall SM, Visvader JE, Biankin AV (2008) Expression of LMO4 and outcome in pancreatic ductal adenocarcinoma. Br J Cancer 98: 537-541
26. Nyberg P (2005) Matrix Degrading Proteases and Collagen-Derived Angiogenesis Inhibitors in the Regulation of Carcinoma Cell Growth. Dissertation Medica D817, University of Oulu: Oulu
27. Obata K, Iwata K, Ichida T, Inoue K, Matsumoto E, Muragaki Y, Ooshima A (1989) One step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clinica Chimica Acta 181: 293 - 303
28. Ohlund D, Ardnor B, Oman M, Naredi P, Sund M (2008) Expression pattern and circulating levels of endostatin in patients with pancreas cancer. Int J Cancer 122: 2805-2810
29. Sandblom G, Granroth S, Rasmussen IC (2008) TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head. Upsala J Med Sci 113: 57-64
30. Schoumacher RA, Ram J, Iannuzzi MC, Bradbury NA, Wallace RW, Hon CT, Kelly DR, Schmid SM, Gelder FB, Rado TA, Frizzell RA (1990) A cystic fibrosis pancreatic adenocarcinoma cell line. Proc Natl Acad Sci USA 87: 4012-4016
31. Slesak B, Harlozinska-Szmyrka A, Knast W, Sedlaczek P, Einarsson R, van Dalen A (2004) TPS and CA 19-9 measurements in the follow-up of patients with pancreatic cancer and chronic pancreatitis. Int J Biol Markers 19: 115 - 119
32. Stallings-Mann M, Radisky D (2007) Matrix metalloproteinase-induced malignancy in mammary epithelial cells. Cells Tissues Organs 185: 104-110
33. Sund M, Hamano Y, Sugimoto H, Sudhakar A, Soubasakos M, Yerramalla U, Benjamin LE, Lawler J, Kieran M, Shah A, Kalluri R (2005) Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci USA 102: 2934-2939
34. Uehara H, Nakaizumi A, Iishi H, Takenaka A, Eguchi H, Ohigashi H, Ishikawa O (2008) In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases. Pancreas 36: 236-240